ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0901

Low Dose Dual Energy CT Scan for the Detection of Bone Marrow Edema and Erosions in Axial Spondyloarthritis

Jonathan Chan1, Savvas Nicolaou1, Yet Yen Yan2, Mahomed Osman3, Hugue Ouellette1 and Sabeena Jalal4, 1University of British Columbia, Vancouver, BC, Canada, 2Changi General Hospital, Singapore, 3Queensland X-ray, Brisbane, Australia, 4Harvard School of Public Health, Boston, USA, Boston, MA

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), Computed tomography (CT), Imaging, Magnetic resonance imaging (MRI), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster II: Imaging in Spondyloarthritis (0897–0907)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Bone marrow edema (BME) and erosions of the sacroiliac (SI) joints are key imaging features in the diagnosis of axial spondyloarthritis (axSpA). MRI with a fluid sensitive sequence is the most common technique for confirming BME but disadvantages include cost and accessibility. Traditional CT is considered superior for detection of erosions but may be limited by radiation exposure. Low dose CT is a technique associated with a similar amount of radiation as conventional radiography and low dose dual energy CT (ldDECT) may be able to detect BME without the need for higher doses of radiation.

We aim to compare the ability of ldDECT and MRI STIR for the detection of BME and erosions of the SI joints in an inception cohort of patients presenting with undiagnosed back pain and psoriasis, iritis, colitis, or positive HLA-B27.

Methods: Consecutive patients ≤ 45 years of age with ≥ 3 months of undiagnosed low back or buttock pain with any one of psoriasis, uveitis, inflammatory bowel disease, or positive HLA-B27 underwent routine clinical evaluation by a rheumatologist for axSpA followed by both MRI and ldDECT of the SI joints done within 3 months of each other.

Two musculoskeletal fellowship trained radiologists were given 17 cases for calibration which were not included in the study. MRI images were scored for presence of BME, presence of large BME lesions, erosions, number of erosions, and radiologist global assessment for presence/absence of sacroiliitis with confidence scale (0-10) blinded to clinical information and ldDECT images. ldDECT images were scored in the same manner and discordant reads were adjudicated by a third radiologist.

Results: 68 patients were recruited with 27 (39.7%) diagnosed with axSpA (mean age 33.2, male 63%, mean symptom duration 8.7 years, HLA-B27 positive 85%). Uveritis, psoriasis, and IBD were present in 20, 23, and 6% of patients respectively.

ldDECT had a sensitivity of 28.9 and 35.3% and a specificity of 90 and 87.5% between two readers for detection of BME compared with MRI (Table 1).

MRI had a sensitivity of 85 and 82.5% and a specificity of 81.5 and 80.8% between two readers for detection of erosions compared with ldDECT.

Inter-reader reliability was higher for MRI detected BME and erosions compared with DECT (Table 2).

Amongst patients who were diagnosed by a rheumatologist as having axSpA (n=27), 21 had sacroiliitis seen on both CT and MRI, 2 only on CT, 1 only on MRI, and 3 on neither.

Conclusion: ldDECT displayed a reduced sensitivity but was highly specific for BME compared to MRI STIR sequence as a reference standard. MRI revealed reasonable sensitivity and specificity for erosions compared to ldDECT as a reference standard. ldDECT has good reproducibility for the interpretation of erosions but has moderate inter-reader reliability for BME.

Amongst patients where BME was detected, 86% had evidence of erosive changes suggesting a marginal benefit with addition of dual energy scanning. Only 1 patient eventually diagnosed with axSpA had sacroiliitis on MRI not seen on ldDECT. Given the potential lower cost and accessibility of ldDECT, further studies may reveal whether utilizing ldDECT as the initial imaging modality would reduce the need for an MRI and thus increase accessibility and reduce costs.


Disclosures: J. Chan, Pfizer, 5, Abbvie, 5, UCB, 2, 5, Novartis, 2, 5, 6, Janssen, 2, 6, Eli Lilly, 2, 6, Sandoz, 2, Roche, 2, Gilead, 2, Merck, 2, Fresenius Kabi, 2; S. Nicolaou, Siemens, 12, UBC has a master reserach agreement with Siemens; Y. Yan, None; M. Osman, None; H. Ouellette, None; S. Jalal, None.

To cite this abstract in AMA style:

Chan J, Nicolaou S, Yan Y, Osman M, Ouellette H, Jalal S. Low Dose Dual Energy CT Scan for the Detection of Bone Marrow Edema and Erosions in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/low-dose-dual-energy-ct-scan-for-the-detection-of-bone-marrow-edema-and-erosions-in-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/low-dose-dual-energy-ct-scan-for-the-detection-of-bone-marrow-edema-and-erosions-in-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology